Aaron Pelta
Corporate Officer/Principal chez MORPHIC HOLDING, INC.
Postes actifs de Aaron Pelta
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| MORPHIC HOLDING, INC. | Corporate Officer/Principal | 01/01/2019 | - |
Historique de carrière de Aaron Pelta
Anciens postes connus de Aaron Pelta
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| X4 Pharmaceuticals (Austria) GmbH | Corporate Officer/Principal | 01/08/2016 | 01/03/2019 |
| AMAG PHARMACEUTICALS, INC. | Corporate Officer/Principal | 18/06/2015 | 01/11/2015 |
Formation de Aaron Pelta
| Tuck School of Business at Dartmouth | Masters Business Admin |
| Tufts University | Undergraduate Degree |
Statistiques
Internationale
| Etats-Unis | 5 |
| Autriche | 2 |
Opérationnelle
| Corporate Officer/Principal | 3 |
| Masters Business Admin | 1 |
| Undergraduate Degree | 1 |
Sectorielle
| Health Technology | 3 |
| Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| MORPHIC HOLDING, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
AMAG Pharmaceuticals, Inc.
 AMAG Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology AMAG Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the manufacture, development, and commercialization of a therapeutic iron compound to treat iron deficiency anemia. Its products include Makena and Feraheme. It focuses on the development and commercialization of Feraheme injection for intravenous use to treat iron deficiency anemia. It also manufactures, develops, and commercializes products derived from its proprietary technology for use in treating human diseases. The company was founded on November 9, 1981 and is headquartered in Waltham, MA. | Health Technology |
| X4 Pharmaceuticals (Austria) GmbH |
- Bourse
- Insiders
- Aaron Pelta
- Expérience